Navigation Links
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/12/2009

d quarter 2009 financial results. Telephone numbers for the live conference call are 877-874-1589 (U.S.) or 719-325-4805 (International). The webcast can be accessed on the Investors page of the Transcept website at www.transcept.com and will be available for replay until close of business on November 27, 2009. A playback of the call will be available through November 27, 2009 by dialing 888-203-1112 (U.S.) or 719-457-0820 (International), replay passcode: 2918743.

About Intermezzo®

Intermezzo® (zolpidem tartrate sublingual tablet), the lead product candidate at Transcept, has the potential to be the first prescription sleep aid specifically approved for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. Intermezzo® is a sublingual low dose formulation of zolpidem, the active agent most commonly prescribed in the United States for the treatment of insomnia. Intermezzo® uses approximately one-quarter to one-third of the dose of active drug contained in currently marketed zolpidem-based sleep aids, in a formulation designed to promote rapid sublingual absorption.

Two Phase 3 clinical studies evaluated 376 patients receiving either Intermezzo® or placebo. In the first study, a sleep laboratory trial using an objective polysomnographic endpoint, Intermezzo® demonstrated a statistically significant decrease versus placebo in the time it took patients to return to sleep as measured by Latency to Persistent Sleep. In the second study, an outpatient trial, Intermezzo® demonstrated a statistically significant decrease in Latency to Sleep Onset, a subjective patient reported endpoint. The most common adverse event seen in these trials was headache (2.7 percent active versus 1.4 percent placebo in the outpatient study).

In Septem
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
2. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
3. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
4. Transcept Pharmaceuticals to Report First Quarter 2009 Results
5. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
6. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
7. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
8. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
9. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
10. Endo Pharmaceuticals and LecTec Settle Patent Dispute
11. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... YORK , March 27, 2015  Delcath ... pharmaceutical and medical device company focused on oncology ... and metastatic liver cancers, announces the reporting of ... Company,s Melphalan Hydrochloride for Injection with the Delcath ... a poster presentation at the Society of Surgical ...
(Date:3/27/2015)... YORK , March 27, 2015 /PRNewswire/ ... the leading source of health information, today ... the new National Action Plan for ... President Obama emphasized the urgency and importance ... on national and global health.    ...
(Date:3/26/2015)... WOODBRIDGE, ON , March 26, 2015 /PRNewswire/ - Pivotal ... specialty pharmaceutical company with a focus on Omega-3 therapies ... March 25, 2015 it issued 763,752 common shares of ... payment of interest for the period of December 5 ... on its outstanding Convertible Notes that is due on ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... MYSTIC, Conn., Nov. 9, 2010 Amarin Corporation plc (Nasdaq: ... Wednesday, November 10, 2010 at 11:00 am Eastern Time (4:00 ... the third quarter, including a progress update of the Company,s ... trials of its lead product candidate AMR101 for treating elevated ...
... 9, 2010 The U.S. Food and Drug Administration ... (CT) brain perfusion scans were accidently exposed to excess ... CT scanners did not malfunction. Instead, it is likely ... these overdoses. However, the FDA has identified a series ...
Cached Medicine Technology:Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010 2FDA Working to Prevent Radiation Overdoses During CT Scans 2FDA Working to Prevent Radiation Overdoses During CT Scans 3
(Date:3/28/2015)... a bite of warm, gooey pepperoni pizza, and your ... stomach, ready to break down your meal. In many ... amok, triggering a burning sensation in the chest. Heartburn ... Americans have heartburn at least once a month. The ... can be stopped. , Heartburn or acid reflux symptoms ...
(Date:3/28/2015)... 28, 2015 Thousands of transvaginal ... by C.R. Bard, Inc. continue to move forward ... Court, Southern District of West Virginia, where Bernstein ... the Plaintiffs’ Steering Committee. According to an ... certain defendants named in those lawsuits leave to ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Emergency Medical ... urgent care in Manhattan, recently commemorated its three-year anniversary ... in Manhattan. In addition to 24-hour urgent care, Emergency ... , At this time, Emergency Medical Care’s ... pain, asthma, chest pain, eye injuries, ear infections, fevers, ...
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... highlighted a problem which could prove critical to organizations ... system testing, a critical aspect of data security, is ... card industry data security report, every major category out ... scanning and penetration testing. “With all the craziness that ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... Leavitt Kicks-Off his First Commentary entitled , "Beware ... The grassroots forum AmericaSpeakOn.org today ... with a commentary from former Health and Human Services ... departing HHS, Leavitt calls the President,s "public option" for ...
... sufferers to break the cycle of suffering,Migraine Million, fundraiser ... can give some women headaches -- literally. Yet, ... and bring flowers. This Mother,s Day, the National ... head-on. If women pay more attention to the ...
... recruitment process by pulling all possible job openings from ... ... Point, NC (Vocus) April 21, 2009 -- BlueSky Medical Staffing Software ... Capture Healthcare Job Feeds (tm), BlueSky’s job aggregation engine. The ...
... to its Dean of three years, the school welcomed Dr. Kimberly O,Reilly, ... ... 2009 -- The School of Health Management bid farewell to its dean ... O,Reilly, D.H.Ed., M.S.W., who served as SHM,s vice dean for the past ...
... Qatar Orthopaedic and,Sports Medicine Hospital was officially named as ... with the opening of the first,FIFA Medical Centre of ... world football,s governing body has proceeded to set a ... that players have,access to high quality football medicine. , ...
... Rights for EvistaINDIANAPOLIS, April 22 Eli Lilly and ... U.S. District Court for the Southern District of Indiana ... of a generic version of Lilly,s medicine Evista(R) (raloxifene ... its final ruling. Teva had indicated it was prepared ...
Cached Medicine News:Health News:AmericaSpeakOn.org Launches Discussion on Health Care Reform 2Health News:My Mother/Myself: Migraine Headaches are Hereditary 2Health News:BlueSky Medical Staffing Software Launches First Job Aggregation Engine App and Releases API for Developers 2Health News:BlueSky Medical Staffing Software Launches First Job Aggregation Engine App and Releases API for Developers 3Health News:School of Health Management Welcomes Interim Dean 2Health News:ASPETAR - Qatar Orthopaedic and Sports Medicine Hospital Named FIFA Medical Centre of Excellence 2Health News:Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene 2Health News:Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene 3
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
... line of Surgical Microscope Accessories includes digital ... optic cables, and fiberoptic retrofits. TTI Medical's ... no. 5,264,928) is the only adaptor that ... on the same adaptor body. It is ...
... line of Surgical Microscope Accessories includes ... lenses, fiber optic cables, and fiberoptic ... Adaptor allows the surgeon to document ... either video or 35mm photography. Many ...
... ACCU-Beam® line of Surgical Microscope Accessories includes ... fiber optic cables, and fiberoptic retrofits. TTI ... pat. no. 5,264,928) is the only adaptor ... cameras on the same adaptor body. It ...
Medicine Products: